Search Results
Oct 16, 2025, 17:31 ET Indolent Lymphoma Market Experiences Significant Growth Amid Evolving Therapeutic Landscape | DelveInsight
Molecular Profiling Advancements in molecular profiling techniques, such as next-generation sequencing (NGS) and circulating tumor DNA (ctDNA) analysis, have enabled the identification of genetic alterations contributing to disease development and progression.
More news about: DelveInsight Business Research, LLP
Oct 15, 2025, 11:00 ET Gaia Dynamics Expands to 28 New Countries and Launches Next-Generation AI Trade Compliance Tools
Dynamics Gaia Dynamics is an AI-driven trade technology platform founded in 2025 in partnership with Andrew Ng's AI Fund. Headquartered in Palo Alto, California, the company leverages cutting-edge artificial intelligence to simplify complex processes in tariff
More news about: Gaia Dynamics
Oct 15, 2025, 08:46 ET Quintara Biosciences Completes Acquisition of Laragen Sanger Sequencing Business, Strengthening Service Continuity and Strategic Expansion in Los Angeles
research community. With operations in Boston, MA; San Fransico, CA; San Diego, CA; Los Angeles, CA; and Houston, TX, Quintara specializes in Sanger, NGS, Nanopore, molecular biology, and recombinant antibody/protein production solutions designed to accelerate discovery and development.
More news about: Quintara Biosciences
Oct 14, 2025, 09:00 ET Carolina Molecular Selected as Certified Service Provider for CS Genetics' Single-Cell Sequencing Platform
MORRISVILLE, N.C. and SAN DIEGO, Oct. 14, 2025 /PRNewswire/ -- Carolina Molecular, a clinical sequencing lab and NGS foundry, and CS Genetics, an emerging leader in single-cell RNA sequencing (scRNA-Seq) technology, today announced that Carolina Molecular has been named
More news about: CS Genetics
Oct 13, 2025, 08:43 ET AccuGenomics and 1Cell.Ai Partner to Bring Ultra-Sensitive Liquid Biopsy Testing Across Asia, with Plans for U.S. Expansion
Collaboration integrates per-sample NGS internal standards with multi-omic precision oncology platform to enhance cancer diagnostics accuracy and access WILMINGTON, N.C.
More news about: AccuGenomics
Oct 09, 2025, 13:31 ET Volta Labs lance un processus automatisé de capture par hybridation Twist sur Callisto
Twist est en mesure de développer des outils NGS très uniformes. Le kit Standard Hybridization v2 de Twist offre aux chercheurs une couverture uniforme et une sensibilité élevée pour leurs régions d'intérêt. « Nous avons conçu nos outils NGS Twist pour permettre à nos clients d'accélérer
More news about: Volta Labs Inc.
Oct 09, 2025, 10:05 ET Volta Labs führt automatisierten Twist-Hybridisierungs-Workflow auf Callisto ein
synthetisieren, ist Twist in der Lage, NGS-Tools mit hoher Einheitlichkeit zu entwickeln. Das Standard Hybridization v2-Kit von Twist bietet Forschenden eine gleichmäßige Abdeckung und hohe Empfindlichkeit für ihre Zielbereiche. „Wir haben unsere Twist NGS-Tools entwickelt, um unseren Kunden
More news about: Volta Labs Inc.
Oct 09, 2025, 10:00 ET Volta Labs Launches Automated Twist Hybridization Capture Workflow on Callisto
synthesize DNA at scale, Twist is able to develop NGS tools with high uniformity. Twist's Standard Hybridization v2 Kit provides researchers with uniform coverage and high sensitivity for their regions of interest. "We've built our Twist NGS tools to empower customers to accelerate their
More news about: Volta Labs Inc.
Oct 09, 2025, 10:00 ET Volta Labs lanza un flujo de trabajo automatizado de captura de hibridación de torsión en Callisto
herramientas NGS con alta uniformidad. El Kit de Hibridación Estándar v2 de Twist ofrece a los investigadores una cobertura uniforme y alta sensibilidad para sus regiones de interés. "Hemos desarrollado nuestras herramientas Twist NGS para
More news about: Volta Labs Inc.
Oct 08, 2025, 12:27 ET Rotary Air Preheaters Market Size to Reach USD 1.8 Billion by 2033, Growing at 5.2% CAGR from 2026-2033 - Market Research Intellect
(High-Performance Liquid Chromatography (HPLC) Testing, Molecular Genetic Testing (DNA-Based), Hemoglobin Electrophoresis, Next-Generation Sequencing (NGS), Point-of-Care (POC) Rapid Tests), By Region, and Forecast to 2033
More news about: Market Research Intellect
Oct 07, 2025, 14:11 ET Circulogene Expands Solid Tumor Genomic Capabilities with Launch of OncoGenDx Tissue Assay
OncoGenDx is a next-generation sequencing (NGS) assay designed to deliver a comprehensive molecular analysis of formalin-fixed paraffin-embedded (FFPE) tumor tissue across all solid tumor types. Built on Roche's AVENIO NGS platform and leveraging FoundationOne's bioinformatics pipeline,
More news about: Circulogene
Oct 07, 2025, 13:22 ET Outubro Rosa: Bioma Genetics alerta para o papel dos exames genéticos na prevenção do câncer de mama e ovário
Bioma, analisa mutações associadas à predisposição hereditária para o câncer de mama e ovário. Utilizando tecnologia de sequenciamento de nova geração (NGS), o exame investiga genes como BRCA1, BRCA2, PALB2, CHEK2 e TP53, entre outros reconhecidos pela comunidade científica internacional.
More news about: Bioma Genetics
Oct 07, 2025, 09:00 ET Golden Helix Receives a NIH SBIR Phase 2 Grant
unique biological needs. With support from the NIH SBIR Grant, Golden Helix will enhance its pharmacogenetic analytics as an integrated component of NGS-based genetic testing, driving more precise and scalable solutions for clinical practice. Research reported in this publication
More news about: Golden Helix Inc
Oct 03, 2025, 07:00 ET AerCap Leased, Purchased and Sold 146 Assets in the Third Quarter 2025
Completed 45 sale transactions for 40 aircraft (including 2 Airbus A320 Family aircraft, 10 Airbus A320neo Family aircraft, 1 Airbus A330, 5 Boeing 737NGs, 7 Boeing 777-300ERs and 5 Embraer E190/E195s from AerCap's owned aircraft portfolio and 10 aircraft from AerCap's managed aircraft portfolio), 4 engines
More news about: AerCap Holdings N.V.
Sep 29, 2025, 13:48 ET Vantage Market Research: Global Companion Diagnostics Market Size & Share to Surpass USD 31.75 Billion by 2035, Growing at a CAGR 11.75% | Powering Precision Medicine, Targeted Therapies and Next-Gen Drug Development
2035. Growth is fueled by the rapid rise of targeted therapies, FDA/EMA co-approvals, and expanding clinical adoption of next-generation sequencing (NGS)-based tests.
More news about: Vantage Market Research
Sep 24, 2025, 06:07 ET People Diagnosed with Lung Cancer Aren't Getting Vital Tests; New Campaign Hopes to Change That
comprehensive biomarker testing are critical to identify next steps and treatment options upon diagnosis. Also known as Next Generation Sequencing, or NGS testing, biomarker testing looks for key markers in a tumor's DNA. Some lung cancer treatments target these characteristics directly, often with fewer
More news about: American Lung Association
Sep 23, 2025, 03:46 ET AI in Oncology For Analytical Solutions Market Size & Share to Surpass $8.86 Billion by 2035, Growing at a CAGR 21% | Vantage Market Research
business models, and regional strategies differ?What breakthrough innovations such as AI-powered imaging, digital pathology, predictive analytics, NGS, and liquid biopsy will
More news about: Vantage Market Research
Sep 22, 2025, 18:06 ET Morse Micro Secures $59 Million Series C Funding to Lead the Next Era of IoT
Ray Stata, Malcolm and Lucy Turnbull, Startmate, and a number of institutional investors including Hostplus, NGS, UniSuper, bringing the company's total funding to over $193 million [$290 million AUD] to
More news about: Morse Micro
Sep 22, 2025, 11:16 ET RNA-based Therapies Market to Reach USD 213.54 Billion by 2033, Driven by Rare Diseases, Oncology, and Advances in RNA Technologies | DataM Intelligence
RNA Sequencing Market to Reach New Peaks as NGS & Single-Cell Platforms Fuel $25B Growth by 2034 About DataM Intelligence DataM Intelligence is
More news about: DataM Intelligence 4 Market Research LLP
Sep 22, 2025, 08:00 ET SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
Boston. The companies aim to improve the diagnosis and treatment of breast and prostate cancer by developing an optimized next generation sequencing (NGS) solution that leverages SOPHiA GENETICS's AI algorithms to detect genetic mutations in the PIK3CA/AKT1/PTEN pathway.
More news about: SOPHiA GENETICS
Sep 22, 2025, 08:00 ET SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
Boston. The companies aim to improve the diagnosis and treatment of breast and prostate cancer by developing an optimized next generation sequencing (NGS) solution that leverages SOPHiA GENETICS's AI algorithms to detect genetic mutations in the PIK3CA/AKT1/PTEN pathway.
More news about: SOPHiA GENETICS
Sep 19, 2025, 10:30 ET In Vitro Diagnostics (IVD) Quality Control Market worth $2.15 billion by 2030 with 5.5% CAGR | MarketsandMarkets™
global burden of infectious diseases, genetic disorders, and cancer, which has accelerated the adoption of molecular testing techniques such as PCR, NGS, and isothermal amplification. The growing demand for personalized medicine, companion diagnostics, and rapid detection of emerging pathogens has further
More news about: MarketsandMarkets
Sep 16, 2025, 11:00 ET Gaia Dynamics Welcomes Carlos Alzate as Chief Technology Officer
Former CTO at Andrew Ng's AI Fund and IBM Research leader brings global expertise in AI and machine learning to advance Gaia's mission of transforming global trade compliance PALO ALTO, Calif.,
More news about: Gaia Dynamics
Sep 15, 2025, 14:00 ET ePlus to Present at Sidoti Small Cap Virtual Conference September 17-18, 2025
HERNDON, Va., Sept. 15, 2025 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS –
More news about: EPLUS INC.
Sep 12, 2025, 10:01 ET Ligase Enzymes Market worth US$0.36 billion by 2030 with 6.8% CAGR | MarketsandMarkets™
period. The ligase enzymes market is growing due to the rising demand for molecular diagnostics, the increasing adoption of next-generation sequencing (NGS), expanding applications in synthetic biology, and continuous advancements in enzyme engineering. The growing use of ligases in molecular diagnostics,
More news about: MarketsandMarkets